Development of CD30 CAR-T cells in refractory or relapsed Hodgkin’s lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of CD30 CAR-T cells in refractory or relapsed Hodgkin’s lymphoma

Published:2023-10-30 Issue:12 Volume:16 Page:1017-1023
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Ma Xiao Chen¹^ORCID,Lv Xiao²,Li Ying¹^ORCID

Affiliation:

1. Department of Haematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, China

2. Department of Haematology, Shan dong Provincial Hospital Affiliated to Shan dong First Medical University; Shan dong Provincial Hospital, Affiliated to Shandong University, Jinan, Shandong Province, China

Funder

the Key Research and Development Program of Shandong Province

the National Natural Science Foundation

the Key Research and Development Project of Jinan

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2023.2276210

Reference56 articles.

1. Hodgkin's lymphoma in adults

2. Hodgkin lymphoma: A review and update on recent progress

3. Long-Term Results of Autologous Stem Cell Transplantation for Primary Refractory or Relapsed Hodgkin’s Lymphoma

4. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin’s disease: a prognostic model for treatment outcomes;Wheeler C;Biol Blood Marrow Transplant,1997

5. A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP